
    
      Healthy, meningococcal-vaccine na√Øve toddlers aged 12 to 23 months were randomized either to
      a single dose of MenACYW Conjugate vaccine alone or in combination with other pediatric
      vaccines in healthy toddlers in South Korea and Thailand (MMR + varicella vaccine), the
      Russian Federation (PCV13), and Mexico (DTaP-IPV-HB-Hib). Immunogenicity (pre- and 30 days
      post-vaccination) and safety was assessed.
    
  